CareDx Announces Board and Executive Changes
Ticker: CDNA · Form: 8-K · Filed: Oct 24, 2025 · CIK: 1217234
Sentiment: neutral
Topics: management-change, executive-compensation, board-of-directors
TL;DR
CareDx shakes up board and exec pay, effective Oct 22.
AI Summary
CareDx, Inc. announced on October 22, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the company reported the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for its key executives. These changes are effective as of October 22, 2025.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can indicate internal restructuring or strategic shifts that may carry inherent risks.
Key Numbers
- 001-36536 — SEC File Number (Identifies the company's filing with the SEC.)
- 94-3316839 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- CareDx, Inc. (company) — Registrant
- October 22, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 8000 Marina Boulevard, 4th Floor Brisbane, California 94005 (address) — Principal Executive Offices
- XDxd, Inc. (company) — Former Company Name
- Expression Diagnostics Inc (company) — Former Company Name
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates the departure of 'certain officers' and 'directors' but does not specify the exact roles or individuals in this section of the 8-K.
Who are the newly elected directors?
The filing states that new directors have been elected, but their names are not provided in the initial summary of the 8-K.
What are the details of the compensatory arrangements for certain officers?
The filing mentions adjustments to 'Compensatory Arrangements of Certain Officers' but does not provide specific details on the nature or value of these arrangements.
What is the effective date of these changes?
The earliest event reported is dated October 22, 2025, which is also the date as of which the changes are reported.
Does this filing indicate any financial performance issues?
This 8-K filing primarily concerns corporate governance changes (director departures/elections and executive compensation) and does not directly report on financial performance.
Filing Stats: 896 words · 4 min read · ~3 pages · Grade level 12 · Accepted 2025-10-24 16:06:08
Key Financial Figures
- $0.001 — nge on which registered) Common Stock, $0.001 Par Value CDNA The Nasdaq Stock Market
- $50,000 — as follows: an annual cash retainer of $50,000 for his service on the Board paid on a
- $400,000 — units having a grant date fair value of $400,000, rounded to the nearest whole share, wh
- $225,000 — units having a grant date fair value of $225,000, rounded to the nearest whole share, wh
Filing Documents
- cdna-20251022.htm (8-K) — 31KB
- 0001217234-25-000051.txt ( ) — 144KB
- cdna-20251022.xsd (EX-101.SCH) — 2KB
- cdna-20251022_lab.xml (EX-101.LAB) — 21KB
- cdna-20251022_pre.xml (EX-101.PRE) — 12KB
- cdna-20251022_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 24, 2025 CAREDX, INC. By: /s/ JOHN W. HANNA John W. Hanna Chief Executive Officer (Principal Executive Officer)